A Quantitative Systems Pharmacology Perspective on Cancer Immunology
The return on investment within the pharmaceutical industry has exhibited an exponential decline over the last several decades. Contemporary analysis suggests that the rate-limiting step associated with the drug discovery and development process is our limited understanding of the disease pathophysi...
Main Authors: | Christina Byrne-Hoffman, David J. Klinke II |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | Processes |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9717/3/2/235 |
Similar Items
-
Mechanisms of Action of Autophagy Modulators Dissected by Quantitative Systems Pharmacology Analysis
by: Qingya Shi, et al.
Published: (2020-04-01) -
Dihydroxypropyl theophylline: its preparation and pharmacological and clinical study
by: Maney, Paul Vance
Published: (1945) -
Unraveling the Connection between Fibroblast Growth Factor and Bone Morphogenetic Protein Signaling
by: Anna Schliermann, et al.
Published: (2018-10-01) -
Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies
by: Shu-Hua Xiao, et al.
Published: (2018-02-01) -
Inhibitory receptor signaling destabilizes immunological synapse formation in primary NK cells
by: Thushara P Abeyweera, et al.
Published: (2013-11-01)